AzTrials
AzTrials

StrokeNEUROCONNNCT06298097

Brain Connectivity Measured With High-density Electroencephalography

A study testing Connectivity measures in people with Stroke, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Emerging scientific results show that disrupted functional connectivity in stroke can explain behavioral impairments and predict their recovery over time. However, no technique is yet available for widespread use in clinics to examine how neural synchronization in brain networks is altered in stroke patients. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
Connectivity measures
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
170 participants
Where
1 siteItaly
Study dates
11 Jun 2020to 2 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • right or left hemisphere damage
  • unilateral stroke
  • compliance with magnetic resonance imaging (e.g., no claustrophobia)
  • compliance with magnetic resonance imaging (e.g., no claustrophobia)
  • Exclusion Criteria (both patients and healthy participants):
  • no comorbidities with psychiatric disorders

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • IRCCS San Camillo Hospital

    Venice

    n.ricercaclinica@hsancamillo.it

    Recruiting

Other trials in Italy

About this study

Official title: Brain Connectivity Measured With High-density Electroencephalography: a Novel Neurodiagnostic Tool for Stroke

Emerging scientific results show that disrupted functional connectivity in stroke can explain behavioral impairments and predict their recovery over time. However, no technique is yet available for widespread use in clinics to examine how neural synchronization in brain networks is altered in stroke patients. This is crucial to determine favorable prognostic factors and to define individualized rehabilitation protocols. Importantly, the investigators have successfully used high-density electroencephalography (hdEEG) in healthy individuals to measure neural synchronization in brain networks. In this project, the investigators will develop methods and tools based on hdEEG for assessing functional connectivity in stroke patients. These methods and tools will be employed to examine how neural changes occurring after brain lesions explain behavioral impairments. The project will open the way for the use of hdEEG at the patient's bedside, as a neurodiagnostic tool for stroke as well as other brain disorders.

Conditions
Stroke
Being tested
Connectivity measures
Keywords
high-density electroencephalography, brain connectivity
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Connectivity measuresDevice

    Electroencephalography connectivity measures will be collected and compared in both stroke patients and healthy participants. Connectivity measures will be extracted using these devices: high-density electroencephalography (using either a 128-channel or a 256-channel system) and magnetic resonance imaging.

Study groups in NCT06298097
Study groupRoleWhat they receive
stroke patientsOtherResting-state networks obtained through electroencephalography will be analyzed in a group of stroke patients.
Receives: Device: Connectivity measures
healthy participantsOtherResting-state networks obtained through electroencephalography will be analyzed in a group of healthy participants.
Receives: Device: Connectivity measures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. High-density electroencephalography measurements (work package 1, 2, and 3)

    High-density electroencephalography measurements, specifically focusing on resting state networks, will be performed using either a 128-channel or a 256-channel system

    Measured: Immediately after the recruiting

  2. High-density electroencephalography measurements (work package 1, 2, and 3)

    High-density electroencephalography measurements, specifically focusing on resting state networks, will be performed using either a 128-channel or a 256-channel system

    Measured: 1 month after the recruiting

  3. High-density electroencephalography measurements (work package 1, 2, and 3)

    High-density electroencephalography measurements, specifically focusing on resting state networks, will be performed using either a 128-channel or a 256-channel system

    Measured: 2 months after the recruiting

  4. High-density electroencephalography measurements (work package 1, 2, and 3)

    High-density electroencephalography measurements, specifically focusing on resting state networks, will be performed using either a 128-channel or a 256-channel system

    Measured: 4 months after the recruiting

  5. High-density electroencephalography measurements (work package 1, 2, and 3)

    High-density electroencephalography measurements, specifically focusing on resting state networks, will be performed using either a 128-channel or a 256-channel system

    Measured: 6 months after the recruiting

  6. Magnetic Resonance Imaging measurement (work package 1, 2, and 3)

    Magnetic Resonance Imaging will be conducted using a 3 Tesla scanner. Specifically, T1-weighted Magnetic Resonance Imaging measure will be collected

    Measured: Immediately after the recruiting

  7. Magnetic Resonance Imaging measurement (work package 1, 2, and 3)

    Magnetic Resonance Imaging will be conducted using a 3 Tesla scanner. Specifically, T1-weighted Magnetic Resonance Imaging measure will be collected

    Measured: 1 month after the recruiting

  8. Magnetic Resonance Imaging measurement (work package 1, 2, and 3)

    Magnetic Resonance Imaging will be conducted using a 3 Tesla scanner. Specifically, T1-weighted Magnetic Resonance Imaging measure will be collected

    Measured: 2 months after the recruiting

  9. Magnetic Resonance Imaging measurement (work package 1, 2, and 3)

    Magnetic Resonance Imaging will be conducted using a 3 Tesla scanner. Specifically, T1-weighted Magnetic Resonance Imaging measure will be collected

    Measured: 4 months after the recruiting

  10. Magnetic Resonance Imaging measurement (work package 1, 2, and 3)

    Magnetic Resonance Imaging will be conducted using a 3 Tesla scanner. Specifically, T1-weighted Magnetic Resonance Imaging measure will be collected

    Measured: 6 months after the recruiting

Secondary outcomes (35)
  1. Muscle strength measurement (work package 3)

    Muscle strength will be measured in the patients by using the Medical Research Council Score

    Measured: Immediately after the recruiting

  2. Muscle strength measurement (work package 3)

    Muscle strength will be measured in the patients by using the Medical Research Council Score

    Measured: 1 month after the recruiting

  3. Muscle strength measurement (work package 3)

    Muscle strength will be measured in the patients by using the Medical Research Council Score

    Measured: 2 months after the recruiting

  4. Muscle strength measurement (work package 3)

    Muscle strength will be measured in the patients by using the Medical Research Council Score

    Measured: 4 months after the recruiting

  5. Muscle strength measurement (work package 3)

    Muscle strength will be measured in the patients by using the Medical Research Council Score

    Measured: 6 months after the recruiting

  6. Sensorimotor impairment measurement (work package 3)

    Sensorimotor impairment will be measured in the patients by using the Upper Extremity Fugl-Meyer index

    Measured: Immediately after the recruiting

  7. Sensorimotor impairment measurement (work package 3)

    Sensorimotor impairment will be measured in the patients by using the Upper Extremity Fugl-Meyer index

    Measured: 1 month after the recruiting

  8. Sensorimotor impairment measurement (work package 3)

    Sensorimotor impairment will be measured in the patients by using the Upper Extremity Fugl-Meyer index

    Measured: 2 months after the recruiting

  9. Sensorimotor impairment measurement (work package 3)

    Sensorimotor impairment will be measured in the patients by using the Upper Extremity Fugl-Meyer index

    Measured: 4 months after the recruiting

  10. Sensorimotor impairment measurement (work package 3)

    Sensorimotor impairment will be measured in the patients by using the Upper Extremity Fugl-Meyer index

    Measured: 6 months after the recruiting

  11. Spasticity measurement (work package 3)

    Spasticity will be measured in the patients by using the Modified Ashworth Score

    Measured: Immediately after the recruiting

  12. Spasticity measurement (work package 3)

    Spasticity will be measured in the patients by using the Modified Ashworth Score

    Measured: 1 month after the recruiting

  13. Spasticity measurement (work package 3)

    Spasticity will be measured in the patients by using the Modified Ashworth Score

    Measured: 2 months after the recruiting

  14. Spasticity measurement (work package 3)

    Spasticity will be measured in the patients by using the Modified Ashworth Score

    Measured: 4 months after the recruiting

  15. Spasticity measurement (work package 3)

    Spasticity will be measured in the patients by using the Modified Ashworth Score

    Measured: 6 months after the recruiting

  16. Funtional skills measurement (work package 3).

    Functional skills will be measured in the patients by using the Functional Independence Measure index. Six domains of function are evaluated: self-care, sphincter control, transfers, locomotion, communication, and social cognition. Self-care activities include dressing, eating, grooming, and bathing.

    Measured: Immediately after the recruiting

  17. Funtional skills measurement (work package 3).

    Functional skills will be measured in the patients by using the Functional Independence Measure index. Six domains of function are evaluated: self-care, sphincter control, transfers, locomotion, communication, and social cognition. Self-care activities include dressing, eating, grooming, and bathing.

    Measured: 1 month after the recruiting

  18. Funtional skills measurement (work package 3).

    Functional skills will be measured in the patients by using the Functional Independence Measure index. Six domains of function are evaluated: self-care, sphincter control, transfers, locomotion, communication, and social cognition. Self-care activities include dressing, eating, grooming, and bathing.

    Measured: 2 months after the recruiting

  19. Funtional skills measurement (work package 3).

    Functional skills will be measured in the patients by using the Functional Independence Measure index. Six domains of function are evaluated: self-care, sphincter control, transfers, locomotion, communication, and social cognition. Self-care activities include dressing, eating, grooming, and bathing.

    Measured: 4 months after the recruiting

  20. Funtional skills measurement (work package 3).

    Functional skills will be measured in the patients by using the Functional Independence Measure index. Six domains of function are evaluated: self-care, sphincter control, transfers, locomotion, communication, and social cognition. Self-care activities include dressing, eating, grooming, and bathing.

    Measured: 6 months after the recruiting

  21. Activities of daily living measurement (work package 3)

    Activities of daily living will be measured in the patients by the Barthel Index

    Measured: Immediately after the recruiting

  22. Activities of daily living measurement (work package 3)

    Activities of daily living will be measured in the patients by the Barthel Index

    Measured: 1 month after the recruiting

  23. Activities of daily living measurement (work package 3)

    Activities of daily living will be measured in the patients by the Barthel Index

    Measured: 2 months after the recruiting

  24. Activities of daily living measurement (work package 3)

    Activities of daily living will be measured in the patients by the Barthel Index

    Measured: 4 months after the recruiting

  25. Activities of daily living measurement (work package 3)

    Activities of daily living will be measured in the patients by the Barthel Index

    Measured: 6 months after the recruiting

  26. Pain measurement (work package 3)

    Pain level will be measured in the patients by the Visual Analog Scale for Pain

    Measured: Immediately after the recruiting

  27. Pain measurement (work package 3)

    Pain level will be measured in the patients by the Visual Analog Scale for Pain

    Measured: 1 month after the recruiting

  28. Pain measurement (work package 3)

    Pain level will be measured in the patients by the Visual Analog Scale for Pain

    Measured: 2 months after the recruiting

  29. Pain measurement (work package 3)

    Pain level will be measured in the patients by the Visual Analog Scale for Pain

    Measured: 4 months after the recruiting

  30. Pain measurement (work package 3)

    Pain level will be measured in the patients by the Visual Analog Scale for Pain

    Measured: 6 months after the recruiting

  31. Cognitive performance measurements (work package 3)

    Cognitive functions will be measured in the patients by using the Oxford Cognitive Screen

    Measured: Immediately after the recruiting

  32. Cognitive performance measurements (work package 3)

    Cognitive functions will be measured in the patients by using the Oxford Cognitive Screen

    Measured: 1 month after the recruiting

  33. Cognitive performance measurements (work package 3)

    Cognitive functions will be measured in the patients by using the Oxford Cognitive Screen

    Measured: 2 months after the recruiting

  34. Cognitive performance measurements (work package 3)

    Cognitive functions will be measured in the patients by using the Oxford Cognitive Screen

    Measured: 4 months after the recruiting

  35. Cognitive performance measurements (work package 3)

    Cognitive functions will be measured in the patients by using the Oxford Cognitive Screen

    Measured: 6 months after the recruiting

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2024
  2. Study start11 Jun 2020
  3. Primary completion2 Feb 2025 (estimated)
  4. Study completion2 Feb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
170 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06298097
Sponsor's protocol ID
2019.11
Acronym
NEUROCONN
Status last verified
Mar 2024
First submitted
13 Feb 2024
Last updated
7 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Connectivity measures in people with Stroke, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dante Mantini (+39 0412207594, dante.mantini@hsancamillo.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

High-density electroencephalography measurements (work package 1, 2, and 3) (time frame: Immediately after the recruiting). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in